140 related articles for article (PubMed ID: 3460807)
1. Potential radiopharmaceuticals for the detection of ocular melanoma. Part II. Iodoquinoline derivatives and 67Ga-citrate.
van Langevelde A; Bakker CN; Boer H; Ilmer TA; Journée-de Korver JA; Kaspersen FM; Noach EL; Oosterhuis JA; Pauwels EK
Eur J Nucl Med; 1986; 12(2):96-104. PubMed ID: 3460807
[TBL] [Abstract][Full Text] [Related]
2. Potential radiopharmaceuticals for the detection of ocular melanoma. Part I. 5-iodo-2-thiouracil derivatives.
van Langevelde A; Bakker CN; Broxterman HJ; Journée-de Korver JG; Kaspersen FM; Oosterhuis JA; Pauwels EK
Eur J Nucl Med; 1983; 8(2):45-51. PubMed ID: 6840126
[TBL] [Abstract][Full Text] [Related]
3. Uptake of 123I-5-iodo-2-thiouracil, a possible radiopharmaceutical for noninvasive detection of ocular melanoma, in melanotic and amelanotic melanomas in hamsters.
Franken NA; Van Langevelde A; Journée-De Korver JG; Bakker CN; Feitsma RI; Van Delft JL; Oosterhuis JA; Pauwels EK
Nucl Med Commun; 1985 Oct; 6(10):657-63. PubMed ID: 4088550
[TBL] [Abstract][Full Text] [Related]
4. Detection of ocular melanoma with 4-(3-dimethylaminopropylamino)-7-[123I]-iodoquinoline.
Lambrecht RM; Packer S; Wolf AP; Lloyd D; Atkins HL
J Nucl Med; 1984 Jul; 25(7):800-4. PubMed ID: 6737079
[TBL] [Abstract][Full Text] [Related]
5. L-3-123I-alpha-methyltyrosine for melanoma detection: a comparative evaluation.
Kloster G; Bockslaff H
Int J Nucl Med Biol; 1982; 9(4):259-69. PubMed ID: 6225742
[TBL] [Abstract][Full Text] [Related]
6. Melanoma affine radiopharmaceuticals I. A comparative study of 131I-labeled quinoline and tyrosine derivatives.
Bubeck B; Eisenhut M; Heimke U; zum Winkel K
Eur J Nucl Med; 1981; 6(5):227-33. PubMed ID: 6788553
[TBL] [Abstract][Full Text] [Related]
7. Localization of 11C-radiopharmaceuticals in the Greene melanoma of hamsters.
Turner JH; Maziere M; Comar D
Eur J Nucl Med; 1985; 10(9-10):392-7. PubMed ID: 3159576
[TBL] [Abstract][Full Text] [Related]
8. Metal isotopes used as radioactive indicators of ocular melanoma.
Packer S; Lambrecht RM; Christman DR; Ansari AN; Wolf AP; Atkins HL
Am J Ophthalmol; 1977 Jan; 83(1):80-94. PubMed ID: 835671
[TBL] [Abstract][Full Text] [Related]
9. Potential radiopharmaceuticals for the detection of ocular melanoma. Part III. A study with 14C and 11C labelled tyrosine and dihydroxyphenylalanine.
van Langevelde A; van der Molen HD; Journée-de Korver JG; Paans AM; Pauwels EK; Vaalburg W
Eur J Nucl Med; 1988; 14(7-8):382-7. PubMed ID: 3141189
[TBL] [Abstract][Full Text] [Related]
10. Radio-iodine-labelled 5-iodo-2-thiouracil: a potential radiopharmaceutical for establishing the viability of ocular melanoma after radiation therapy.
Franken NA; Van Langevelde A; Pauwels EK; Journée-de Korver JG; Bakker CN; Oosterhuis JA
Nucl Med Commun; 1986 Nov; 7(11):797-809. PubMed ID: 3554049
[TBL] [Abstract][Full Text] [Related]
11. Gallium-67 citrate in the detection of ocular malignant melanoma.
Camps JA; Oosterhuis JA; van Langevelde A; Pauwels EK; Stijnen T
Nucl Med Commun; 1987 Jan; 8(1):62. PubMed ID: 3472128
[No Abstract] [Full Text] [Related]
12. Scintimetric detection of choroidal malignant melanoma with [123I]-5-iodo-2-thiouracil.
Franken NA; van Delft JL; van Langevelde A; Bleeker JC; de Wolff-Rouendaal D; van Best JA; Bouwhuis-Hoogerwerf ML; Oosterhuis JA; Pauwels EK
Ophthalmologica; 1986; 193(4):248-54. PubMed ID: 3587880
[TBL] [Abstract][Full Text] [Related]
13. Tumor detection with radiopharmaceuticals.
Packer S
Semin Nucl Med; 1984 Jan; 14(1):21-30. PubMed ID: 6369546
[TBL] [Abstract][Full Text] [Related]
14. Visualization of ocular melanoma with N-isopropyl-p-[123I]-iodoamphetamine.
Ono S; Fukunaga M; Otsuka N; Nagai K; Morita K; Furukawa T; Muranaka A; Yanagimoto S; Tomomitsu T; Tabuchi A
J Nucl Med; 1988 Aug; 29(8):1448-50. PubMed ID: 3404259
[TBL] [Abstract][Full Text] [Related]
15. Quinoline analog labeled with iodine 123 in melanoma detection.
Packer S; Redvanly C; Lambrecht RM; Wolf AP; Atkins HL
Arch Ophthalmol; 1975 Jul; 93(7):504-8. PubMed ID: 1138696
[TBL] [Abstract][Full Text] [Related]
16. Noncontact detection of ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine: first clinical results.
Bockslaff H; Kloster G; Dausch D; Schad K; Hundeshagen H
Graefes Arch Clin Exp Ophthalmol; 1982; 219(3):149-54. PubMed ID: 7173627
[TBL] [Abstract][Full Text] [Related]
17. Noncontact detection of experimental amelanotic ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine.
Bockslaff H; Spitznas M; Hahn I; Kloster G
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 217(4):255-66. PubMed ID: 6915722
[TBL] [Abstract][Full Text] [Related]
18. [Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].
Sillaire-Houtmann I; Bonafous J; Veyre A; Mestas D; D'Incan M; Moins N; Kemeny JL; Chossat F; Bacin F
J Fr Ophtalmol; 2004 Jan; 27(1):34-9. PubMed ID: 14968075
[TBL] [Abstract][Full Text] [Related]
19. Radiolabeled porphyrin vs gallium-67 citrate for the detection of human melanoma in athymic mice.
Maric N; Chan SM; Hoffer PB; Duray P
Int J Rad Appl Instrum B; 1988; 15(5):543-51. PubMed ID: 3254877
[TBL] [Abstract][Full Text] [Related]
20. [67Ga-citrate SPECT imaging of the isolated right ventricle heart metastatic malignant melanoma in a patient with chest pain].
Dolezal J; Vizd'a J; Klzo L
Vnitr Lek; 2008 Sep; 54(9):862-5. PubMed ID: 18924347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
